IndiaMTF — home
Stock

ALIVUS

Alivus Life Sciences Limited
Health Technology

Daily Margin Trading Facility book for ALIVUS across NSE and BSE, from 10 Nov 2025. All figures in ₹ crore, derived from exchange public disclosures.

Funded value
₹33 Cr
as of 10 Sep 2026
Rank in book
#837
100 days tracked
Share of book
0.02%
of the whole NSE + BSE book
Peak funded
₹33 Cr
on 10 Sep 2026
Largest single-day addition
+₹12 Cr
on 02 Sep 2026
Largest single-day unwind
−₹4 Cr
on 16 Feb 2026

NSE & BSE split

How ALIVUS’s funded book divides across the two exchanges, as of 10 Sep 2026.
NSE
NSE ₹32 Cr · 97.3%BSE ₹1 Cr · 2.7%

MTF vs Price

Margin-funded outstanding for ALIVUS in ₹ crore against the closing price, adjusted for splits and bonuses. Each window uses the same reference date as the table below, so the two agree. Funded value moves with the price on its own, so the line under the chart reads the share count instead — that is what shows whether more stock is genuinely being borrowed against.
MTF book (₹ Cr)

Shares under margin

Number of shares funded via MTF over time (NSE + BSE combined).

Rank trajectory

Where ALIVUS has sat in the funded-value ranking each day (1 = most funded). Lower is more prominent.

ALIVUS — last 30 trading days

Combined NSE + BSE funded value, day-on-day change, share of the whole book, and rank. Newest first.
DateCombined (₹ Cr)Day Δ (₹ Cr)% of bookRank
10 Sep 202633+₹00.02%837
09 Sep 202633+₹40.02%836
08 Sep 202629+₹00.02%892
07 Sep 202629+₹10.02%891
04 Sep 202628+₹20.02%903
03 Sep 202626+₹10.02%933
02 Sep 202625+₹120.02%953
07 Apr 202613−₹00.01%995
06 Apr 202614−₹10.01%985
02 Apr 202614−₹00.01%962
01 Apr 202615+₹10.01%955
30 Mar 202614+₹00.01%974
27 Mar 202614+₹00.01%980
24 Mar 202614−₹00.01%996
20 Mar 202614+₹00.01%994
18 Mar 202614+₹00.01%998
17 Mar 202614−₹00.01%1000
09 Mar 202614−₹00.01%999
06 Mar 202614+₹00.01%995
05 Mar 202614+₹00.01%997
04 Mar 202614−₹00.01%997
02 Mar 202614−₹00.01%993
27 Feb 202614+₹00.01%993
26 Feb 202614+₹00.01%986
25 Feb 202614−₹00.01%996
24 Feb 202614+₹00.01%995
23 Feb 202614+₹00.01%995
20 Feb 202614−₹00.01%999
19 Feb 202614−₹00.01%998
18 Feb 202615—0.01%992

ALIVUS within Health Technology

Ranked #51 of 61 funded Health Technology stocks, carrying 0.5% of that sector’s margin book. Nearest names by funded value:
#StockMTF book (₹ Cr)% of sector
49AKUMS
Akums Drugs and Pharmaceuticals Limited
₹340.5%
50RUBICON
Rubicon Research Limited
₹330.5%
51ALIVUS
Alivus Life Sciences Limited
₹330.5%
52ALKEM
Alkem Laboratories Limited
₹320.5%
53ASTRAZEN
AstraZeneca Pharma India Limited
₹310.5%

All Health Technology stocks and how the sector has moved →

Disclaimer. Data sourced from daily margin trading disclosure provided by NSE and BSE. This website and page are meant for educational and information only — not investment advice. MTF is leveraged and can amplify losses. Rules, margins, rates and eligible-stock lists change; verify current details with your broker and SEBI/exchange circulars. IndiaMTF.com is not a SEBI-registered intermediary, broker, or investment adviser and has no affiliation with SEBI, NSE or BSE. Figures are reproduced from publicly disclosed exchange data, may be delayed or revised, and should be independently verified before any trading decision. Consult a SEBI-registered investment adviser before investing.